Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Jake2212's Profile
Displaying 1-50 of 323 result(s).
CYDY CytoDyn Inc
05/15/2025 9:38:27 PM
Kat: In terms of the need to temper (19)
CYDY CytoDyn Inc
05/15/2025 9:51:26 AM
Scotty: Totally agree that the prev (18)
CYDY CytoDyn Inc
05/14/2025 11:19:34 AM
mfgiola: Thanks for the info re Roc (13)
CYDY CytoDyn Inc
05/13/2025 3:35:36 PM
Riz: Great find (with credit to Upw (21)
CYDY CytoDyn Inc
05/13/2025 9:16:40 AM
Nobody is mentioning that the quote (19)
CYDY CytoDyn Inc
05/09/2025 11:30:27 AM
Ken: I'll take your kewpie doll and (15)
CYDY CytoDyn Inc
05/07/2025 7:14:03 PM
ohm: My post was exactly what I rep (23)
CYDY CytoDyn Inc
05/06/2025 11:15:38 PM
Plotinus: I hardily concur with you (9)
CYDY CytoDyn Inc
05/06/2025 10:52:11 PM
chaz: Sorry to upset you by conjuri (20)
CYDY CytoDyn Inc
05/06/2025 7:51:44 PM
mountaineer: Great post. Loved it. (3)
CYDY CytoDyn Inc
05/06/2025 7:07:01 PM
The intriguing implications of hiri (25)
CYDY CytoDyn Inc
05/05/2025 9:12:50 PM
Scotty: According to the pithy mess (7)
CYDY CytoDyn Inc
05/05/2025 5:16:11 PM
Ken: It seems to me that your tea l (5)
CYDY CytoDyn Inc
05/05/2025 3:34:49 PM
I just heard from Mightycydy, one o (24)
CYDY CytoDyn Inc
05/05/2025 1:27:39 PM
Riz: Another great find. As you poi (21)
CYDY CytoDyn Inc
05/05/2025 9:39:39 AM
Sam: I have to acknowledge the vali (5)
CYDY CytoDyn Inc
05/04/2025 10:56:18 PM
Riz: Great find re CYDY reps listed (22)
CYDY CytoDyn Inc
04/29/2025 4:09:27 PM
Sunray: Not to nitpick, but the tit (5)
CYDY CytoDyn Inc
04/29/2025 10:25:58 AM
misui: 28 patients, but only 19 rec (9)
CYDY CytoDyn Inc
04/29/2025 10:17:25 AM
Hoops: I doubt that you are overrea (18)
CYDY CytoDyn Inc
04/22/2025 4:42:29 PM
MGK: ohm, calling ohm. (1)
CYDY CytoDyn Inc
04/09/2025 12:51:51 PM
3Putt: As I recall, CYDY has stated (12)
CYDY CytoDyn Inc
04/07/2025 5:49:48 PM
ohm: Although it would be presumptu (7)
CYDY CytoDyn Inc
04/04/2025 9:48:25 AM
FKA: I like your idea of bringing o (10)
CYDY CytoDyn Inc
04/03/2025 11:13:09 PM
brentie: Great find. Article is ver (8)
CYDY CytoDyn Inc
04/03/2025 1:41:31 PM
My69: Thanks for the clarification. (1)
CYDY CytoDyn Inc
04/03/2025 12:50:53 PM
My69: I believe Trodelvy's OS for m (8)
CYDY CytoDyn Inc
04/01/2025 8:33:25 PM
House: Dr Jay explained that all of (5)
CYDY CytoDyn Inc
04/01/2025 5:08:45 PM
Evil: I sent an email to IR recentl (5)
CYDY CytoDyn Inc
04/01/2025 4:00:30 PM
cardamine: I get the concern that y (17)
CYDY CytoDyn Inc
03/31/2025 7:48:43 PM
Ritz: your point about only 28 mTNB (17)
CYDY CytoDyn Inc
03/31/2025 5:51:42 PM
sean: I fear you are misinterpretin (20)
CYDY CytoDyn Inc
03/29/2025 10:52:57 PM
My69: You are misreading the Nov 20 (12)
CYDY CytoDyn Inc
03/26/2025 12:32:33 PM
Kat: Please clarify, if you can, th (3)
CYDY CytoDyn Inc
03/24/2025 6:55:33 PM
Ken: This is where I do not know wh (1)
CYDY CytoDyn Inc
03/24/2025 5:39:39 PM
Chazzle: a decrease in CTCs reliabl (4)
CYDY CytoDyn Inc
03/24/2025 12:30:18 PM
dfw: ohm responded to your query ju (15)
CYDY CytoDyn Inc
03/23/2025 7:02:25 PM
CYDY may be positioned to seek acce (31)
CYDY CytoDyn Inc
03/18/2025 8:14:34 PM
biloxi: Thanks for your excellent s (24)
CYDY CytoDyn Inc
03/15/2025 12:00:17 PM
Sean: Perhaps because Michelle Kilc (18)
CYDY CytoDyn Inc
03/05/2025 4:54:17 PM
sherlock: Thank you for an extremel (4)
CYDY CytoDyn Inc
03/02/2025 4:15:15 PM
Is Gilead seriously in play to inve (41)
CYDY CytoDyn Inc
02/24/2025 5:27:14 PM
Jeff: Re "pre-clinical trials" for (27)
CYDY CytoDyn Inc
02/24/2025 11:55:36 AM
Jeff: Right on re Merck, and add th (6)
CYDY CytoDyn Inc
02/15/2025 11:08:30 PM
Respert: My good friend, I agree an (14)
CYDY CytoDyn Inc
02/15/2025 4:15:14 PM
Ken: Keep thinking. Being the tirel (6)
CYDY CytoDyn Inc
02/15/2025 2:41:02 PM
Buddyboy: Great find on a major hed (10)
CYDY CytoDyn Inc
01/22/2025 6:43:21 PM
Ken: The threshold requiring shareh (10)
CYDY CytoDyn Inc
12/09/2024 11:17:39 AM
Ken: I suspect that you are being o (6)
CYDY CytoDyn Inc
11/27/2024 12:35:39 PM
Ken and Ohm: In my humble opinion y (12)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Understanding the Art of Giving for a Change in Humanity
  • Çelebi Aviation's Commitment to ETHICS and Compliance
  • Arcadis Achieves Key Milestones with Shareholder Support and Dividend Approval
  • CHAI's Rapid Growth Positions It for Incredible Valuation Spike
  • Revolutionary Advances in Treating Resistant Hypertension
  • Revolutionary Advances in Hypertension Management for Patients
  • GMI Cloud Expands Headquarters to Propel AI Innovation
  • Important Update for Investors in Compass Diversified Holdings
  • Understanding the Iovance Biotherapeutics Class Action Lawsuit
  • Investors Alert: Class Action Against Viatris Inc. - VTRS
  • Investors Urged to Act on NET Power Class Action Lawsuit
  • Unlock Daily Passive Income with Leading Cloud Mining Firm
  • Unlocking the Future of Cloud Mining with ALL4 Mining
  • WuXi Biologics Celebrates Milestone Approval of Innovative Therapy
  • CureGene's CG-0416: A Revolutionary Approach to Obesity Management
  • Transformative Success: Silver Star Properties' Self-Storage Growth
  • Light Energia S.A. Concludes Cash Tender Offer with Key Results
  • SHARC Energy Secures Vital Short-Term Funding for Growth
  • Franno's Debut Album: A New Era for Latin Music Enthusiasts
  • GoldHaven Resources Provides Important Project Update
  • Lasola's Market Sold: A New Chapter for Community Deli
  • A Deep Dive into Consensus 2025 and Future Events
  • SolarMax Technology Posts Strong Q1 Results, Sees Growth Ahead
  • Texas Southern University Celebrates One Year of Progress
  • Groundbreaking Blood Test Receives FDA Nod for Alzheimer's Aid
  • Fintiv's Legal Triumph Against Apple in Patent Dispute
  • Talisker Resources Secures Up to $3 Million in Funding
  • Celebrating Community Spirit: LGI Homes' Service Impact Day
  • NextGen Digital Platforms Achieves Successful Funding Milestone
  • Breakthrough in Alzheimer's Testing with FDA's Approval
  • Eldorado Gold Corporation Faces Investigation Over Investor Claims
  • Iovance Biotherapeutics Secures New Opportunities for Growth
  • North American Construction Group Reports 2025 Shareholder Votes
  • Hi-View Resources Implements Share Consolidation for Growth
  • Zeigler Auto Group Expands Luxury Portfolio with Acquisition
  • Fashion Footwear LLC Wins Landmark Case Against Iconix Brand Group
  • Vanda Pharmaceuticals to Present Insights at Key Summit 2025
  • Unlock Daily Earnings with Savvy Mining and Dogecoin Insights
  • Caliber Achieves Compliance with Key Nasdaq Listing Standards
  • Aventis Energy Initiates Strategic Marketing Partnership
  • LOBO EV Technologies Navigates Nasdaq Compliance Challenges
  • Rivalry Corp. Updates on Management Cease Trade Order Status
  • Birchcliff Energy Reports Successful Annual Meeting Results
  • Magnetic North Acquisition Corp. Closes Initial Placement Successfully
  • Valley National Bancorp's Upcoming Redemption of Subordinated Notes
  • Investors Urged to Join Lawsuit Against Avis Budget Group, Inc.
  • Understanding the Class Action Lawsuit Against BigBear.ai
  • Explore Your Dream Home at Richmond American's New Community
  • Investors Can Pursue Compensation in Bakkt Holdings Class Action
  • Investors Can Take Action in Actinium Pharmaceuticals Case
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site